Validation of the Type 1 Insulin-Like Growth Factor Receptor as a Therapeutic Target in Renal Cancer

Molecular Cancer Therapeutics - United States
doi 10.1158/1535-7163.mct-09-0101
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)


Related search